Sanitas, Compensar, Bupa and Ribera Salud interested in Cafesalud
Sanitas, Compensar, Bupa y Ribera Salud estarían interesadas en Cafesalud
Intel ID : 244550
| Synopsis |
|
Sanitas, a Spain-based provider of health services, British United Provident Association (BUPA) (LSE:BUPF), a UK-based insurance company, Ribera Salud, a Spain-based healthcare services provider, and Comprnsar, a Colombia-based health services provider, may be interested in acquiring Cafesalud EPS, a Colombia-based health services provider, reported Portafolio on 19 January 2017, citing sources familiar with the matter. According to the report, Cafesalud EPS, currently for sale, would put other assets on the block, such as EPS Cruz Blanca and Epsifarma and, to acquire the entity, the buyer must demonstrate financial solvency and experience in the provision of services for at least 1,500,000 members. Specifically, the company already defined the regulations of the sale and added that, within two weeks, the data room is opening with the information for potential buyers to evaluate the situation and make their offers (see related intel).
(content in spanish)
Grupo Sanitas, empresa española dedicada a la prestación de servicios de salud, British United Provident Association (BUPA) (LSE: BUPF) empresa británica de seguros, Ribera Salud, empresa española de servicios sanitarios, y Compensar, empresa colombiana de servicios de salud, estarían interesadas en adquirir Cafesalud EPS, prestadora de servicios de salud con sede en Colombia, según ha informado Portafolio el 19 de enero de 2017, citando fuentes cercanas al asunto. La compañía, actualmente en venta, tendría en venta otros activos como la EPS Cruz Blanca y Epsifarma y, para adquirir la entidad, el comprador deberá acreditar solvencia económica y una experiencia en la prestación de servicios para por lo menos 1.500.000 afiliados. En concreto, la compañía ya ha definido el reglamento de venta y en febrero abrirá el cuarto de datos con toda la información para que los potenciales compradores valoren la situación y hagan sus ofertas (ver Intels relacionados). |
|
||||
| Intel ID | 244550 | ||
| Value | ND | ||
| Native Currency |
US Dollar (USD)
Exchange Rate: |
||
| Date |
|
||
| Country | ![]() |
||
| Region | |||
| Continent | ![]() |
||
| Geography | ![]() |
||
| Subsector (Old TTR Sectors) |
|
||
| Type |
|
||
| Intel Grade |
|
||
| Source |
|
||
| Tags | ![]() |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
25.02.04 Life & Health Insurance 25 Financial Services / 25.02 Insurance |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.03.02 Clinics & Primary Care 30 Healthcare / 30.03 Healthcare Facilities & Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
25.02.04 Life & Health Insurance 25 Financial Services / 25.02 Insurance |
||
| Secondary Sectors (TTRSC) |
30.03.08 Hospitals 30 Healthcare / 30.03 Healthcare Facilities & Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.03.08 Hospitals 30 Healthcare / 30.03 Healthcare Facilities & Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
50.01.02 Government Administration 50 Public Services & NGOs / 50.01 Government & Public Administration |
||
| Secondary Sectors (TTRSC) |
25.02.04 Life & Health Insurance 25 Financial Services / 25.02 Insurance |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.
